Celescreen Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $35.7K
Latest Deal Amount
  • Investors
  • 1

Celescreen General Information

Description

Developer of alternative toxicology testing methods. The company uses C. elegans worms to test the toxicity levels of consumer products in the fields of pharmaceuticals, cosmetics, and food products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Primary Office
  • 96 Bis Boulevard Raspail
  • 75006 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Celescreen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 20-Aug-2019 $35.7K 000.00 00000 Completed Product Development
2. Angel (individual) 13-Apr-2017 000.00 000.00 00000 Completed Product Development
1. Accelerator/Incubator 11-Sep-2014 Completed Product Development
To view Celescreen’s complete valuation and funding history, request access »

Celescreen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 16,000 $1.114790 $2.68 $2.68 1x $2.68 29.09%
To view Celescreen’s complete cap table history, request access »

Celescreen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
To view Celescreen’s complete investors history, request access »